XML 89 R71.htm IDEA: XBRL DOCUMENT v3.25.1
ADDITIONAL INFORMATION-CONDENSED FINANCIAL STATEMENTS OF THE PARENT COMPANY (Tables)
12 Months Ended
Dec. 31, 2024
ADDITIONAL INFORMATION-CONDENSED FINANCIAL STATEMENTS OF THE PARENT  
Schedule of condensed statements of operations

​

​

​

​

​

​

​

​

​

​

​

    

For the year ended December 31

​

    

2022

    

2023

    

2024

​

    

RMB

    

RMB

    

RMB

    

USD

​

​

​

​

​

​

​

​

(note 2 (al))

​

​

(RMB in thousands)

Net revenue

 

—

​

—

​

—

​

—

Cost of revenues

 

—

​

—

​

—

​

—

​

​

​

​

​

​

​

​

​

Gross profit

 

—

​

—

​

—

​

—

​

​

​

​

​

​

​

​

​

Total operating expenses

 

(593,204)

​

(590,323)

​

(324,964)

​

(44,520)

​

​

​

​

​

​

​

​

​

Loss from operations

 

(593,204)

​

(590,323)

​

(324,964)

​

(44,520)

​

​

​

​

​

​

​

​

​

Share of income from subsidiaries and affiliates

 

1,264,720

​

4,055,054

​

93,252

​

12,775

​

​

​

​

​

​

​

​

​

Interest income/(expenses), net

 

(19,867)

​

3,414

​

(10,308)

​

(1,412)

Exchange gain/(loss)

 

(18,586)

​

10,831

​

(26,914)

​

(3,687)

Change in fair value of convertible senior notes

 

(12,083)

​

(31,188)

​

323,474

​

44,316

Income before income taxes

 

620,980

​

3,447,788

​

54,540

​

7,472

Income tax expenses

 

(474)

​

(345)

​

—

​

—

Net income attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders

 

620,506

​

3,447,443

​

54,540

 

7,472

Schedule of condensed balance sheets

​

​

​

​

​

​

​

​

​

    

December 31, 2023

    

December 31, 2024

​

    

RMB

    

RMB

    

USD

​

​

​

​

​

​

(note 2 (al))

​

​

(RMB in thousands)

ASSETS

​

​

​

​

​

  

Current assets:

 

​

 

​

​

  

Cash and cash equivalent

 

414,689

​

124,313

​

17,031

Due from subsidiaries

 

380,447

​

358,722

​

49,145

Other current assets

 

1,637

​

2,049

​

281

Total current assets

 

796,773

​

485,084

​

66,457

Investments in subsidiaries

 

20,354,397

​

19,608,702

​

2,686,381

Total assets

 

21,151,170

​

20,093,786

​

2,752,838

​

​

​

​

​

​

​

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

​

​

​

​

​

Current liabilities:

 

​

​

​

​

​

Due to subsidiaries

 

25,829

​

26,214

​

3,591

Short-term borrowings

​

179,425

​

162,140

​

22,213

Convertible senior notes

​

782,969

​

—

​

—

Other current liabilities

 

6,513

​

6,523

​

895

Total current liabilities

 

994,736

​

194,877

​

26,699

​

​

​

​

​

​

​

Shareholders’ equity:

 

​

 

​

​

​

Ordinary shares (US$0.00002 par value, 500,000,000 shares authorized, 209,920,447 and 211,083,301 shares issued as of December 31, 2023 and December 31, 2024, respectively)

 

29

 

29

​

4

Additional paid-in capital

 

10,738,376

​

11,245,665

​

1,540,650

Accumulated other comprehensive loss

 

359,584

​

225,141

​

30,844

Treasury stock, at cost; 1,360,000 and 5,574,244 ordinary shares as of December 31, 2023 and December 31, 2024

 

(79,282)

 

(216,507)

​

(29,661)

Retained earnings

 

9,137,727

​

8,644,581

​

1,184,302

Total shareholders’ equity

 

20,156,434

​

19,898,909

​

2,726,139

​

​

​

​

​

​

​

Total liabilities and shareholders’ equity

 

21,151,170

​

20,093,786

​

2,752,838

Schedule of condensed cash flows

​

​

​

​

​

​

​

​

​

​

​

    

For the year ended December 31, 

​

    

2022

    

2023

    

2024

​

    

RMB

    

RMB

    

RMB

    

USD

​

​

​

​

​

​

​

​

(note 2 (al))

​

​

(RMB in thousands)

Cash flows from operating activities:

 

  

 

  

 

  

 

  

Net income

 

620,506

​

3,447,443

​

54,540

​

7,472

Adjustments to reconcile net income to net cash used in operating activities:

 

​

 

​

 

​

 

​

Share based compensation charges

​

579,368

​

582,596

​

319,452

​

43,765

Change in fair value of convertible senior notes

 

12,083

​

31,188

​

(323,474)

​

(44,316)

Share of income from subsidiaries

 

(1,264,720)

​

(4,055,054)

​

(93,252)

​

(12,775)

Exchange (gain)/loss

 

18,586

​

(10,831)

​

26,914

​

3,687

Changes in operating assets and liabilities:

 

​

 

​

 

​

 

​

Decrease in due from subsidiaries

 

1,465,778

​

(206,412)

​

—

​

—

Decrease in due from a related party

​

3,292

​

3,454

​

—

​

—

(Increase)/decrease in other current assets

 

(1,279)

​

34

​

—

​

—

Increase/(Decrease) in due to subsidiaries

 

(1,445,183)

​

25,829

​

385

​

53

Decrease in due to a related party

​

(12,142)

​

—

​

—

​

—

Increase/(decrease) in other current liabilities

 

(6,403)

​

(460)

​

10

​

1

Net cash used in operating activities

​

(30,114)

​

(182,213)

​

(16,222)

​

(2,222)

​

​

​

​

​

​

​

​

​

Cash flows from investing activities:

 

​

​

​

​

​

​

​

Cash collection for loans from subsidiaries

​

735,673

​

553,984

​

633,977

​

86,854

Cash paid for loans to subsidiaries

​

(289,620)

​

—

​

—

​

—

Net cash used in investing activities

 

446,053

​

553,984

​

633,977

​

86,854

​

​

​

​

​

​

​

​

​

Cash flows from financing activities:

 

​

 

​

 

​

 

​

Proceeds from exercise of share options

 

5,024

​

—

​

3,691

​

506

Repurchase of shares

 

—

​

(79,282)

​

(874,964)

​

(119,870)

Repayments of borrowing

​

—

​

—

​

(543,675)

​

(74,483)

Proceeds from bank borrowings

​

—

​

179,425

​

526,390

​

72,115

Dividend distribution

​

—

​

(559,599)

​

(547,686)

​

(75,034)

Dividends received from a subsidiary (offset with loans to the subsidiary)

​

—

​

—

​

550,880

​

75,470

Net cash provided by/(used in) financing activities

​

5,024

​

(459,456)

​

(885,364)

​

(121,296)

​

​

​

​

​

​

​

​

​

Effect of foreign exchange rate changes on cash and cash equivalents

 

36,710

 

9,934

 

(22,767)

 

(3,118)

​

 

​

 

​

 

​

 

​

Net increase/(decrease) in cash and cash equivalents

​

457,673

​

(77,751)

​

(290,376)

​

(39,781)

Cash and cash equivalents, beginning of year

 

34,767

​

492,440

​

414,689

​

56,812

​

​

​

​

​

​

​

​

​

Cash and cash equivalents, end of year

 

492,440

​

414,689

​

124,313

​

17,031

​

​

​

​

​

​

​

​

​

Supplemental disclosure of non-cash investing and financing cash flow information

​

​

​

​

​

​

​

​

Proceeds from exercise of share options received in subsequent period

​

1,169

​

—

​

—

​

—

Conversion of convertible senior notes to ordinary shares

​

340,330

​

247,290

​

465,167

​

63,728

Offset of dividend receivable with loans to a subsidiary

​

—

​

—

​

610,000

​

83,570